ARS Pharmaceuticals SPRY Slides 2 as Biotech Sentiment Weighs on NearTerm Momentum Plus500 Reports 11 Quarterly Revenue Growth Confirms FullYear Guidance TRP Q1 2026 Earnings Slight EPS Miss Clouds Outlook as Revenue Details Remain Unreported US Tipping Culture Spills Overseas A Global Economic Shift